0.6256
전일 마감가:
$0.6597
열려 있는:
$0.6615
하루 거래량:
1.20M
Relative Volume:
1.32
시가총액:
$53.90M
수익:
$2.24M
순이익/손실:
$-136.67M
주가수익비율:
-0.2732
EPS:
-2.29
순현금흐름:
$-102.08M
1주 성능:
+7.71%
1개월 성능:
+10.47%
6개월 성능:
-30.49%
1년 성능:
-73.71%
Century Therapeutics Inc Stock (IPSC) Company Profile
명칭
Century Therapeutics Inc
전화
215-981-4000
주소
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
IPSC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IPSC
Century Therapeutics Inc
|
0.6256 | 56.84M | 2.24M | -136.67M | -102.08M | -2.29 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-08-08 | 개시 | Rodman & Renshaw | Buy |
2023-08-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2022-12-27 | 개시 | Chardan Capital Markets | Buy |
2022-10-31 | 개시 | Guggenheim | Buy |
2022-10-10 | 개시 | Canaccord Genuity | Buy |
2022-05-23 | 개시 | H.C. Wainwright | Buy |
2022-05-12 | 개시 | William Blair | Mkt Perform |
2021-07-13 | 개시 | BofA Securities | Buy |
2021-07-13 | 개시 | JP Morgan | Overweight |
2021-07-13 | 개시 | Piper Sandler | Overweight |
모두보기
Century Therapeutics Inc 주식(IPSC)의 최신 뉴스
What drives Century Therapeutics Inc. stock priceHigh-yield portfolio picks - PrintWeekIndia
What analysts say about Century Therapeutics Inc. stockJaw-dropping returns - PrintWeekIndia
Layoff Tracker: Flagship Unicorns Tessera, Generate:Biomedicines Downsize - BioSpace
Century Therapeutics Inc. Stock Analysis and ForecastTremendous growth potential - Autocar Professional
Published on: 2025-07-22 15:49:56 - jammulinksnews.com
All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy - Yahoo Finance
Is Century Therapeutics Inc. a good long term investmentMarket-leading capital gains - jammulinksnews.com
What institutions are buying Century Therapeutics Inc. stock nowFree Step-by-Step Investment Guide - Newser
University City biotech Century Therapeutics is cutting 72 jobs, about half its workforce - MSN
Why Century Therapeutics Inc. stock attracts strong analyst attentionMarket Trend Watch - Newser
Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com
Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN
How Century Therapeutics Inc. stock performs during market volatilityFree Stock Market Query - Newser
What makes Century Therapeutics Inc. stock price move sharplyRisk Limited High Gain Trades - Newser
Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock - Yahoo Finance
Why OBIO stock attracts strong analyst attentionHigh Yield Stock Selection - Newser
Company’s Banking Stock: Dissecting a 51.83% Quarterly Revenue Decline Amid Growth - investchronicle.com
Century Therapeutics (NASDAQ:IPSC) Shares Down 0.9% – What’s Next? - Defense World
CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com
Century Therapeutics to reduce headcount by 51% - MarketScreener
Century Therapeutics Announces Major Workforce Reduction - TipRanks
Century Therapeutics' Bold Restructuring: A Strategic Pivot to Deliver Transformative Therapies - AInvest
Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum - Nasdaq
Head-To-Head Contrast: Quince Therapeutics (NASDAQ:QNCX) and Century Therapeutics (NASDAQ:IPSC) - Defense World
Century Therapeutics Holds Annual Stockholder Meeting By Investing.com - Investing.com South Africa
Century Therapeutics Holds Annual Stockholder Meeting - Investing.com Australia
Century Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks
66,797 Shares in Century Therapeutics, Inc. (NASDAQ:IPSC) Acquired by Two Sigma Investments LP - Defense World
Jane Street Group LLC Increases Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Century Therapeutics Inc (IPSC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):